Pizzocaro G, Piva L, Nicolai N
Divisione di Urologia, Istituto Nazionale per lo Studio e la Cura dei Tumori (INT), Milano.
Arch Ital Urol Androl. 1996 Jun;68(3):169-72.
Between 1964 and 1990 inclusive, 204 consecutive naive patients with penile cancer and 14 patients with recurrence in the inguinal nodes have been referred at INT, Milano. Nodal metastases occurred in 100% of category T3, T4 patients, in 82% T2, in 60% G2-3 T1 and only in 16.5% of G1 T1. Out of the 47 patients who had primary ileoinguinal lymphadenectomy, 16 (34%) had negative nodes, versus 100% metastases in the 25 patients operated during the follow-up. The relapse rate was 45% in the 31 patients treated only surgically in the 1964-77 period, versus 16% in the 25 cases submitted to adjuvant chemotherapy between 1978 and 1990. All 4 relapses in the adjuvant treatment group occurred in the 8 patients with bilateral metastases. Twenty-six patients had fixed inguinal nodes: the first 10 were treated with radiotherapy, with or without methotrexate or bleomycin, and the last 16 have been submitted to neoadjuvant chemotherapy. Only one patient of the first group could be operated and all 10 died of cancer within 3 years. On the contrary, 9 (56%) of the 16 patients treated with neoadjuvant chemotherapy could undergo subsequent surgery and 5 (31%) are alive disease free since over 5 years. Prophylactic lymphadenectomy may be indicated in all T2, T3, T4 patients and in indifferentiated T1 tumors. Adjuvant and neoadjuvant chemotherapy can improve the results of radical surgery, significantly.
在1964年至1990年(含)期间,米兰国家肿瘤研究所(INT)共接收了204例初治阴茎癌患者以及14例腹股沟淋巴结复发患者。T3、T4期患者的淋巴结转移率为100%,T2期为82%,G2 - 3 T1期为60%,而G1 T1期仅为16.5%。在47例行原发性髂腹股沟淋巴结清扫术的患者中,16例(34%)淋巴结阴性,而在随访期间接受手术的25例患者中转移率为100%。在1964 - 1977年期间仅接受手术治疗的31例患者中,复发率为45%,而在1978年至1990年期间接受辅助化疗的25例患者中复发率为16%。辅助治疗组的4例复发均发生在8例双侧转移的患者中。26例患者存在固定的腹股沟淋巴结:前10例接受了放疗,联合或不联合甲氨蝶呤或博来霉素,后16例接受了新辅助化疗。第一组中只有1例患者能够接受手术,所有10例患者均在3年内死于癌症。相反,接受新辅助化疗的16例患者中有9例(56%)能够接受后续手术,5例(31%)在5年多后仍无病存活。所有T2、T3、T4期患者以及未分化T1肿瘤患者均可能需要进行预防性淋巴结清扫术。辅助化疗和新辅助化疗可显著提高根治性手术的效果。